pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,552
stories
May 5, 26
STAT+: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease
stat
May 5, 26
Opinion: The ‘brain drain’ narrative about health professionals misses half of the story
stat
May 4, 26
Opinion: Mifepristone court ruling makes drug development riskier for everyone
stat
May 4, 26
Celcuity strengthens case for ASCO-spotlighted breast cancer drug
biopharma dive
May 4, 26
With $97M, Latus pursues a different kind of Huntington’s gene therapy
biopharma dive
May 4, 26
STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news
stat
May 4, 26
STAT+: Biotech raises $42 million to run Huntington’s disease trial
stat
May 1, 26
Arvinas’ ‘Protac’ breast cancer drug cleared by FDA
biopharma dive
May 1, 26
FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data
endpoints
May 1, 26
Summit’s ‘self-inflicted’ stumble; Esperion’s take-private deal
biopharma dive
May 1, 26
FDA approval for Alzheimer's agitation drug; Esperion goes private in $1.1B deal
endpoints
May 1, 26
PFAS is still in some infant formula
stat
Apr 30, 26
Krazati fails confirmatory trial in colorectal cancer, putting approval at risk
endpoints
Apr 30, 26
Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier
stat
Apr 30, 26
UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy
biopharma dive
Apr 30, 26
Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launch
biopharma dive
Apr 30, 26
STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more
stat
Apr 30, 26
Avalyn, in pursuit of better lung drugs, banks $300M in an IPO
biopharma dive
Apr 29, 26
STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
stat
Apr 29, 26
Teva nabs experimental Tourette drug in $700M Emalex buyout
biopharma dive
Apr 29, 26
Chiesi to buy KalVista in $1.9B deal for rare disease drug
biopharma dive
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 29, 26
Food safety experts warn of USDA brain drain
stat
Apr 28, 26
STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic access
stat
Apr 28, 26
Rocket's PRV goes for $180M; Oruka targets $500M offering
endpoints
Apr 28, 26
Incyte claims double Phase 3 win in vitiligo, will file for approval
endpoints
Apr 28, 26
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
biopharma dive
Apr 28, 26
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
stat
Apr 28, 26
FDA claims trial 'manipulation' tainted approval of ChemoCentryx drug
endpoints
Apr 28, 26
Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
biopharma dive
← prev
page 51 of 52
next →